These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12077247)

  • 1. Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins.
    Mothé BR; Sidney J; Dzuris JL; Liebl ME; Fuenger S; Watkins DI; Sette A
    J Immunol; 2002 Jul; 169(1):210-9. PubMed ID: 12077247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.
    Wu Y; Gao F; Liu J; Qi J; Gostick E; Price DA; Gao GF
    J Immunol; 2011 Dec; 187(12):6382-92. PubMed ID: 22084443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239.
    Loffredo JT; Sidney J; Piaskowski S; Szymanski A; Furlott J; Rudersdorf R; Reed J; Peters B; Hickman-Miller HD; Bardet W; Rehrauer WM; O'Connor DH; Wilson NA; Hildebrand WH; Sette A; Watkins DI
    J Immunol; 2005 Nov; 175(9):5986-97. PubMed ID: 16237093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
    Loffredo JT; Sidney J; Wojewoda C; Dodds E; Reynolds MR; Napoé G; Mothé BR; O'Connor DH; Wilson NA; Watkins DI; Sette A
    J Immunol; 2004 Oct; 173(8):5064-76. PubMed ID: 15470050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection.
    Reed JS; Sidney J; Piaskowski SM; Glidden CE; León EJ; Burwitz BJ; Kolar HL; Eernisse CM; Furlott JR; Maness NJ; Walsh AD; Rudersdorf RA; Bardet W; McMurtrey CP; O'Connor DH; Hildebrand WH; Sette A; Watkins DI; Wilson NA
    Immunogenetics; 2011 Dec; 63(12):789-807. PubMed ID: 21732180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins.
    Sidney J; Dzuris JL; Newman MJ; Johnson RP; Kaur A; Amitinder K; Walker CM; Appella E; Mothe B; Watkins DI; Sette A
    J Immunol; 2000 Dec; 165(11):6387-99. PubMed ID: 11086077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape.
    Chu F; Lou Z; Chen YW; Liu Y; Gao B; Zong L; Khan AH; Bell JI; Rao Z; Gao GF
    J Immunol; 2007 Jan; 178(2):944-52. PubMed ID: 17202356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.
    Allen TM; Mothé BR; Sidney J; Jing P; Dzuris JL; Liebl ME; Vogel TU; O'Connor DH; Wang X; Wussow MC; Thomson JA; Altman JD; Watkins DI; Sette A
    J Virol; 2001 Jan; 75(2):738-49. PubMed ID: 11134287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.
    Loffredo JT; Sidney J; Bean AT; Beal DR; Bardet W; Wahl A; Hawkins OE; Piaskowski S; Wilson NA; Hildebrand WH; Watkins DI; Sette A
    J Immunol; 2009 Jun; 182(12):7763-75. PubMed ID: 19494300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
    Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI
    J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Analysis of the Endogenous Peptidomes Displayed by HLA-B*27 and Mamu-B*08: Two MHC Class I Alleles Associated with Elite Control of HIV/SIV Infection.
    Marcilla M; Alvarez I; Ramos-Fernández A; Lombardía M; Paradela A; Albar JP
    J Proteome Res; 2016 Mar; 15(3):1059-69. PubMed ID: 26811146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
    Allen TM; Sidney J; del Guercio MF; Glickman RL; Lensmeyer GL; Wiebe DA; DeMars R; Pauza CD; Johnson RP; Sette A; Watkins DI
    J Immunol; 1998 Jun; 160(12):6062-71. PubMed ID: 9637523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.
    Mothé BR; Horton H; Carter DK; Allen TM; Liebl ME; Skinner P; Vogel TU; Fuenger S; Vielhuber K; Rehrauer W; Wilson N; Franchini G; Altman JD; Haase A; Picker LJ; Allison DB; Watkins DI
    J Virol; 2002 Jan; 76(2):875-84. PubMed ID: 11752176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides.
    Schafer JL; Ries M; Guha N; Connole M; Colantonio AD; Wiertz EJ; Wilson NA; Kaur A; Evans DT
    PLoS Pathog; 2015 Sep; 11(9):e1005145. PubMed ID: 26333068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.
    Newberg MH; Kuroda MJ; Charini WA; Miura A; Lord CI; Schmitz JE; Gorgone DA; Lifton MA; Kuus-Reichel K; Letvin NL
    Virology; 2002 Sep; 301(2):365-73. PubMed ID: 12359438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Specialist Macaque MHC Class I Molecule with HLA-B*27-like Peptide-Binding Characteristics.
    de Groot NG; Heijmans CMC; de Ru AH; Janssen GMC; Drijfhout JW; Otting N; Vangenot C; Doxiadis GGM; Koning F; van Veelen PA; Bontrop RE
    J Immunol; 2017 Nov; 199(10):3679-3690. PubMed ID: 29021373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
    Loffredo JT; Bean AT; Beal DR; León EJ; May GE; Piaskowski SM; Furlott JR; Reed J; Musani SK; Rakasz EG; Friedrich TC; Wilson NA; Allison DB; Watkins DI
    J Virol; 2008 Feb; 82(4):1723-38. PubMed ID: 18057253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.
    Sette A; Sidney J; Bui HH; del Guercio MF; Alexander J; Loffredo J; Watkins DI; Mothé BR
    Immunogenetics; 2005 Apr; 57(1-2):53-68. PubMed ID: 15747117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.